ANMAT – Bioquivalence requirements under consultation [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2016-04-13 15:12 (2906 d 03:44 ago) – Posting: # 16198
Views: 5,446

Hi cbertoncini,

❝ Recently ANMAT issued a new document for consultation (ANMAT-MED-BIO-006-00, only in Spanish unfortunately) in which they reset bioequivalence requirements. If the document is approved, bioequivalence will be only required for products registered not longer than 5 years ago and for newly registered products. Older registered products would not require bioequivalence anymore.


I don’t understand the highlighted parts. The ANMAT’s BE-requirements (2006, amended 2007) are pretty detailed. Is it possible that a generic product was registered without demonstrating BE?

❝ Are you guys aware of any agency that has ever issued such a regulation?


In the EU the market authorisation is initially valid for five years and becomes valid for an unlimited period upon renewal acc. to Regulation (EC) No 726/2004, Article 14, 1–3. See the Questions & Answers and linked documents. In the renewal procedure BE studies which lead to the MA generally (!) are not assessed again.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,638 registered users;
90 visitors (1 registered, 89 guests [including 8 identified bots]).
Forum time: 17:56 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5